Lista de obras -

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

scientific article published on 14 August 2019

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment

artículo científico publicado en 2016

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

artículo científico publicado en 2019

Advances and perspectives of PARP inhibitors

artículo científico publicado en 2019

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor

artículo científico publicado en 2019

CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer

artículo científico publicado en 2020

D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery

artículo científico publicado en 2015

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

artículo científico publicado en 2014

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

scientific article published on 11 November 2019

EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases

artículo científico publicado en 2018

EGFR-TKIs resistance via EGFR-independent signaling pathways

artículo científico publicado en 2018

Effectiveness of comprehensive social support interventions among elderly patients with tuberculosis in communities in China: a community-based trial

artículo científico publicado en 2018

Emerging roles of Nrf2 signal in non-small cell lung cancer

artículo científico publicado en 2016

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis

artículo científico publicado en 2015

Gut microbiome and cancer immunotherapy

scientific article published on 23 January 2019

Gut microbiome modulates efficacy of immune checkpoint inhibitors.

artículo científico publicado en 2018

Identification of Risk Factors of Multidrug-Resistant Tuberculosis by using Classification Tree Method

artículo científico publicado en 2017

Immune pressures drive the promoter hypermethylation of neoantigen genes

scientific article published on 29 November 2019

In vitro evaluation of the inhibitory potential of pharmaceutical excipients on human carboxylesterase 1A and 2

artículo científico publicado en 2014

Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation

artículo científico publicado en 2017

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis

artículo científico publicado en 2015

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer

scientific article published on 06 September 2016

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer

artículo científico publicado en 2019

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

artículo científico publicado en 2014

Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action

artículo científico publicado en 2019

Relationship between the SER treatment period and prognosis of patients with small cell lung cancer

artículo científico publicado en 2014

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

scientific article published on 30 March 2019

Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres

artículo científico publicado en 2015

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells

artículo científico publicado en 2019

The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

scientific article published on 25 October 2019

The role of gut microbiota in immune checkpoint inhibitor therapy

artículo científico publicado en 2018

The role of neoantigen in immune checkpoint blockade therapy

scientific article published on 16 November 2018

[Progress of platelet derived grow factor family in non-small cell lung cancer].

artículo científico publicado en 2014

miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.

artículo científico publicado en 2014

Lista de obras de

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

Advances and perspectives of PARP inhibitors

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor

CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer

D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases

EGFR-TKIs resistance via EGFR-independent signaling pathways

Effectiveness of comprehensive social support interventions among elderly patients with tuberculosis in communities in China: a community-based trial

Emerging roles of Nrf2 signal in non-small cell lung cancer

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis

Gut microbiome and cancer immunotherapy

Gut microbiome modulates efficacy of immune checkpoint inhibitors.

Identification of Risk Factors of Multidrug-Resistant Tuberculosis by using Classification Tree Method

Immune pressures drive the promoter hypermethylation of neoantigen genes

In vitro evaluation of the inhibitory potential of pharmaceutical excipients on human carboxylesterase 1A and 2

Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action

Relationship between the SER treatment period and prognosis of patients with small cell lung cancer

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres

Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells

The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

The role of gut microbiota in immune checkpoint inhibitor therapy

The role of neoantigen in immune checkpoint blockade therapy

[Progress of platelet derived grow factor family in non-small cell lung cancer].

miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1.